Nicotine Transdermal System Patch, Extended Release
Product Images NDC 37808-461

2 FDA label images from H-e-b · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nicotine Transdermal System (NDC 37808-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H-e-b, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

21 mg Carton (21 mg Step 1)

21 mg Carton (21 mg Step 1)
The packaging label for H-E-B Clear Nicotine Transdermal System Patch 21 mg/24h, Step 1, designed as a stop smoking aid. The box contains 14 extended-release transdermal patches delivering 21 mg of nicotine over 24 hours. The front highlights the product name, strength, step, and intended use, including behavior support program details and usage instructions based on cigarette consumption. The label includes warnings, directions for use, inactive ingredients, safety precautions, and a barcode on the back and sides. The labeler is H-E-B.*
FDA Label Image

14 mg Carton (14 mg Step 2)

14 mg Carton (14 mg Step 2)
Box label for H-E-B Nicotine Transdermal System Patch, 14 mg/24 hours, Step 2 strength. The extended-release patch is used as a stop smoking aid and includes 14 patches per box. The label features dosage instructions, usage warnings, inactive ingredients (acrylate adhesive, polyester, silicone adhesive), and a behavior support program with self-help guide. It specifies the product is not for sale to persons under 18, requires proof of age, and cannot be verified from vending machines or other sources.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.